[PCRX] YoY Quarter Result on 30-Jun-2020 [#Q2]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
06-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- -189.09%
YoY- -366.26%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 169,467 169,411 135,590 75,505 102,604 84,107 70,934 15.61%
PBT 37,854 22,007 25,648 -7,311 1,127 2,599 -19,713 -
Tax 12,091 2,131 6,567 -42 -1,603 35 30 171.65%
NP 25,763 19,876 19,081 -7,269 2,730 2,564 -19,743 -
Tax Rate -31.94% -9.68% -25.60% - 142.24% -1.35% - -
Total Cost 143,704 149,535 116,509 82,774 99,874 81,543 90,677 7.97%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 15.20 11.73 14.07 -9.63 2.66 3.05 -27.83 -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS 0.56 0.40 0.43 -0.17 0.07 0.06 -0.49 -
EPS Diluted 0.49 0.38 0.42 -0.17 0.06 0.06 -0.49 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.